Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (8797)	7/4/2003 5:15:25 AM
From: Icebrg	Read Replies (1) \| Respond to of 52153

>>You might also include CLL and PDLI, the first of which looks also looks undervalued to me (nb the Yahoo market cap is wrong by a factor of 2).>> Too high or too low? ;-). Non-US companies - regardless of industry - normally have big problems reaching US valuation levels. Yes, I was aware of PDLI. I just didn't want to start a third section. My intention was not so much to give a complete overview over the billion+ contenders, but more to point out that some of these valuations do look strange. No-one has yet come forward and said that they think ImClone looks cheap and has an interesting upside. What I really find "fascinating" are the number of companies without any approved product with valuations approaching or even exceeding USD 2 billion. That's a lot of money - even in times with a declining dollar value. Erik